Shanghai company founded in 2013 supplying catalogue and custom cell culture media - CHO, HEK293, vaccine and hybridoma platforms - alongside end-to-end biologics CDMO services covering antibody discovery, cell line development and banking, process development, QC and pilot manufacturing.
No comments available.
Leave your rating & comment